Q1 2026 earnings call recap: occupancy up, ICE trends, raised EPS/EBITDA guidance, and Clinical Solutions Pharmacy deal—read key takeaways.
Analysts at Canaccord were similarly optimistic, stating that Fluence Energy’s two new master supply agreements with hyperscalers are a game-changer for the company. Shares of Fluence Energy Inc.